CAR - T Daaweynta unugyada, CAR T Therapy, GARGAARKA GARGAARKA, wakiilka chimeric
U Quus Qoto dheer ee CAR T Therapy: Sidee bay u shaqeysaa?
Soo hel sayniska ka dambeeya CAR T daawaynta unug ee Hindiya! Sahami sida daawayntan kacaanka ahi ay ugu beddesho unugyada difaaca jidhka dagaalyahannada kansarka. Akhri blog-keena hadda si aad wax badan uga ogaato daawayntan mucjisada ah iyo sida ..
GARGAARKA GARGAARKA, Daaweynta CAR, immunotherapy, Daaweynta unugyada T
CAR T-Cell Therapy ma laga heli karaa Hindiya?
Weligaa ma is weydiisay inay jirto hab awood leh oo lagula dagaallamo kansarka? Bal qiyaas haddii aad maalin uun ka heshay rajada dagaalka aad kula jirto kansarka, daawaynta u adeegsata awoodda habka difaaca jidhkaaga si aad u beegsato
IDH1 isbedel, olutasidenib, myeloid leukemia ba'an refractory, Rezlidhia
Olutasidenib waxa u ansixisay FDA dib u soo noqoshada ama dib u laabashada leukemia ba'an ee myeloid leukemia oo leh isbedel IDH1 u nugul
Dec 2022: Kaabsoosha Olutasidenib (Rezlidhia) waxa ansixisay Maamulka Cuntada iyo Dawooyinka (FDA) bukaanada qaangaarka ah ee qaba soo noqnoqoshada ama adkaysiga u leh myeloid leukemia (AML) kuwaas oo leh isbedel IDH1 u nugul sida aqoonsiga.
Asparaginase erwinia chrysanthemi, Dawooyinka Jazz, Rylaze
Dawaynta qiyaasta cusub ee asparaginase erwinia chrysanthemi (recombinant) waxaa ansixiyay FDA
Diseembar 2022: Jadwal cusub oo Isniin-Arbaca-Jimce ah oo loogu talagalay asparaginase erwinia chrysanthemi (recombinant) -rywn waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka (Rylaze, Jazz Pharmaceuticals). Bukaan-socodka waa in ay helaan 25 mg/m.
ivosidenib, NCT03173248, Adeegga Pharmaceuticals LLC, Tibsovo
Ivosidenib oo lagu daray azacitidine ayaa loo oggolaaday cudurka 'myeloid leukemia' ee dhowaan la helay.
Juun 2022: Ivosidenib (Tibsovo, Servier Pharmaceuticals LLC) oo ay weheliso azacitidine waxa u ansixiyay Maamulka Cunnada iyo Dawooyinka ee cusub ee laga helay cudurka leukemia myeloid leukemia (AML) ee dadka waaweyn 75 sano ama ka weyn oo leh ...
AZA-JMML-001, Shirkadda Celgene, ilmo-galeenka myelomonocytic leukemia, NCT02447666, Vidaza
Azacitidine waxa u ansixisay FDA looguna talagalay da'yarta myelomonocytic leukemia ee dhawaan la ogaaday
Juun 2022: FDA waxay ansixisay dawada azacitidine (Vidaza, Celgene Corp.) ee carruurta dhawaan la ogaaday ee myelomonocytic leukemia (JMML) .
leukemia carruurnimada, Leukemias dabadheeraad ah, daweynta kiimoterabiga induction, Leukemia, leukemia carruurta
Leukemia caruurnimada iyo daawadeeda
Leukemia in childhood Leukemia is the most common cancer in children and teens, accounting for almost 1 out of 3 cancers. Most childhood leukemias are acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). Chronic leu..
Burkitt lymphoma, Burkitt u eg lymphoma, DLBCL, Genentech, Rituxan, Rituximab
Rituximab plus chemotherapy waxaa u ogolaatay FDA ee tilmaamayaasha kansarka carruurta
Maarso 2022: Maamulka Cuntada iyo Dawooyinka ayaa ansixiyay rituximab (Rituxan, Genentech, Inc.) iyada oo lala kaashanayo kiimoterabiga loogu talagalay CD20-positive diffuse big B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), Burkitt-like lymphoma.
Asciminib, myeloid leukemia joogto ah, Novartis AG, Ph+ CML, Koromosoomyada Philadelphia, Scemblix
Asciminib waxaa loo ansixiyay Philadelphia chromosome-positive chronic myeloid leukemia
Noofambar 2021: Asciminib (Scemblix, Novartis AG) waxaa siisay ogolaansho degdeg ah Maamulka Cuntada iyo Dawooyinka ee bukaanada qaba Philadelphia chromosome-positive chronic myeloid leukemia (Ph + CML) ee marxaladda dabadheeraatay (CP) kuwaas oo lahaa pr..
Ball, Brexucabtagene autoleucel, Kite Pharma, Tecartus, ZUMA-3
Brexucabtagene autoleucel waxa u ansixisay FDA dib u soo noqoshada ama dib u soo noqoshada unugyada B-cell ee leukemia ba'an
October 2021: Brexucabtagene autoleucel (Tecartus, Kite Pharma, Inc.) has been approved by the Food and Drug Administration for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL). In..